Workflow
Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference
CocrystalCocrystal(US:COCP) Globenewswireยท2025-09-03 12:00

Company Overview - Cocrystal Pharma, Inc. is a clinical-stage biotechnology company focused on developing innovative antiviral treatments for diseases such as influenza, viral gastroenteritis, COVID, and hepatitis [3] - The company utilizes unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs [3] Upcoming Event - James Martin, CFO and co-CEO of Cocrystal, will present a company overview at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025, at 12:00 p.m. Eastern time [1] - Mr. Martin will be available for in-person and virtual one-on-one meetings throughout the conference [2] - Institutional investors and industry professionals can register to attend the conference either virtually or in-person at the Lotte New York Palace Hotel [2]